Works matching DE "DISEASE progression"


Results: 5000
    1
    2
    3
    4
    5
    6

    Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-59744-9
    By:
    • Arrieta, Oscar;
    • Lara-Mejía, Luis;
    • Rios-Garcia, Eduardo;
    • Caballé-Perez, Enrique;
    • Cabrera-Miranda, Luis;
    • Ramos-Ramírez, Maritza;
    • Dávila-Dupont, David;
    • Cardona, Andrés F.;
    • Cruz-Rico, Graciela;
    • Remon, Jordi;
    • Garcilazo-Reyes, Alexandra;
    • Rosell, Rafael
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50